Menu
Scroll to top
Topic: pharmaceutical industry
How the battle over biologics helped stall the Trans Pacific Partnership

How the battle over biologics helped stall the Trans Pacific Partnership

Deborah Gleeson and Ruth Lopert write: Talks that were meant to finalise the Trans Pacific Partnership wound up in Hawaii late last week without reaching a final deal. Over the last five years, 12 countries – Australia, Brunei, Canada, Chile, Japan, Malaysia, Mexico, New Zealand, Peru, Singapore, the United States and Vietnam – have been […]

How diseases get defined, and what that means for you

How diseases get defined, and what that means for you

Ray Moynihan writes: Have you ever wondered how diseases get defined? How “high” does your blood pressure have to be before it’s called “high blood pressure”? How “low” does bone density have to be before it’s “osteoporosis”? How big does the “deficit” have to be before a small child is labelled as having “attention deficit […]

The Health Wrap: on politics, policy, research, and developments in Aboriginal health

The Health Wrap: on politics, policy, research, and developments in Aboriginal health

By Kellie Bisset A little bit political As the nation adjusted to the news of a new Prime Minister, it was still unclear at the time of writing whether Health Minister Tanya Plibersek would retain her position. The AMA wasted no time in calling for Kevin Rudd to put health front and centre at the […]

The Health Wrap: Tobacco control, Closing the Gap, patient safety, pharma sagas and more

The Health Wrap: Tobacco control, Closing the Gap, patient safety, pharma sagas and more

By Kellie Bisset Tobacco control was a dominant issue this fortnight, but Closing the Gap on Indigenous health inequality, barriers to evidence-informed policy, patient safety and immunisation were also on the agenda. Here are some highlights. Towards a smoke-free zone World No Tobacco Day on 31 May saw accusations levelled at the Queensland Government for […]

Fixing Australia’s bad drug deal could save $1.3 billion a year

Fixing Australia’s bad drug deal could save $1.3 billion a year

Stephen Duckett, Health Program Director at the Grattan Institute, writes: The Commonwealth could save A$1.3 billion each year by reforming the Pharmaceutical Benefits Scheme (PBS), according to a report released today by the Grattan Institute. The report, Australia’s bad drug deal, shows that if the PBS simply paid prices for drugs that many Australian public […]

Sign up for greater transparency around the ties between medical industry and health professionals

Sign up for greater transparency around the ties between medical industry and health professionals

If you’d like to see more open disclosure of the financial ties between the medical industry and health professionals, you might like to consider signing this petition. Public health campaigner Associate Professor Ken Harvey, of La Trobe University’s School of Public Health, explains some of the background to his petition below. *** Pushing for US-style […]

A mega-wrap of public health and policy reading from Croakey contributors

A mega-wrap of public health and policy reading from Croakey contributors

Croakey readers are welcome to sign up for (rather irregular) summaries of posts. If you’d like to join the mailing list, please send your email or leave it below. Here is the latest compilation, covering articles posted between 11 April and 3 September. As always, thanks are due to the many contributors who generously volunteer […]

A multi-national MasterChef for Medicines?

A multi-national MasterChef for Medicines?

Imagine millions of viewers around the world glued to their screens of choice for a MasterChef-style competition between medicines, where the winner receives a multi-million dollar prize for delivering the greatest health benefits.  This intriguing idea and other issues relating to the marketing of medicines is discussed by health economist Professor Gavin Mooney who expands […]

What many patients want to know, but many doctors don’t want to tell

What many patients want to know, but many doctors don’t want to tell

Here is an interesting juxtaposition of two sets of research findings about doctors’ disclosures of their financial relationships with pharmaceutical companies… In the US, a survey of almost 2,000 doctors found nearly two-fifths did not completely agree they should disclose their financial relationships with drug and device companies to patients. The survey, by researchers from […]

Should pharma industry fines be used in good works that create positive industry PR?

Should pharma industry fines be used in good works that create positive industry PR?

Andrew Roberts – who is better known to friends, patients, colleagues and Twitter followers as Robbo – is a pharmacist in a remote WA community. Below is an article cross-posted from his blog, Biting the Dust, in which he raises concerns about the source of funds for a dialysis truck that is providing a much-needed […]